SANTA MONICA, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today announced that Arie Belldegrun, M.D., FACS, President and Chief Executive Officer, will present a company overview at the Cowen and Company 35th Annual Health Care Conference on Monday, March 2, 2015 at 1:30 p.m. Eastern Time. The conference will be held at The Boston Marriott Copley Place Hotel in Boston, MA.
A live audio webcast of the presentation can be accessed through the Calendar of Events section of the Company's website at ir.kitepharma.com. A replay of the webcast will be available on the Company's website for two weeks following the presentation.
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT™ designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.
CONTACT: Claudine Prowse, Ph.D.
Kite Pharma, SVP, Corporate Communications and
Investor Relations
(310) 824-1987
cprowse@kitepharma.com
For Media: Justin JacksonBurns McClellan
(212) 213-0006
jjackson@burnsmc.com
Kite Pharma, Inc.News Provided by Acquire Media
